D.A. Davidson & Co.

SEC CIK: 0001080107
Latest filing: Jul 24, 2026

SEC filings (opens in a new tab)

ABBV holding history

AbbVie Inc. in every 13F filed by D.A. Davidson & Co., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABBV overview All 13F holders of ABBV Full Q2 2026 holdings

Shares (Q2 2026): 243,700
Value: $61.3M
% of portfolio: 0.3%
Quarters held: 22; Since Q1 2021

Holdings of ABBV by D.A. Davidson & Co., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	243,700	$61.3M	0.3%	−28,907−10.6%	Reduced	Holders
Q1 2026	272,607	$59.3M	0.4%	+1,491+0.5%	Added	Holders
Q4 2025	271,116	$61.9M	0.4%	+20,169+8.0%	Added	Holders
Q3 2025	250,947	$58.1M	0.4%	−393−0.2%	Reduced	Holders
Q2 2025	251,340	$46.7M	0.3%	−1,293−0.5%	Reduced	Holders
Q1 2025	252,633	$52.9M	0.4%	+2,807+1.1%	Added	Holders
Q4 2024	249,826	$44.4M	0.4%	+3,181+1.3%	Added	Holders
Q3 2024	246,645	$48.7M	0.4%	−4,733−1.9%	Reduced	Holders
Q2 2024	251,378	$43.1M	0.4%	+1,930+0.8%	Added	Holders
Q1 2024	249,448	$45.4M	0.4%	−285−0.1%	Reduced	Holders
Q4 2023	249,733	$38.7M	0.4%	−4,332−1.7%	Reduced	Holders
Q3 2023	254,065	$37.9M	0.4%	+3,436+1.4%	Added	Holders
Q2 2023	250,629	$33.8M	0.4%	−8,341−3.2%	Reduced	Holders
Q1 2023	258,970	$41.2M	0.5%	−33,381−11.4%	Reduced	Holders
Q4 2022	292,351	$47.3M	0.6%	+2,424+0.8%	Added	Holders
Q3 2022	289,927	$39.1M	0.5%	−8,523−2.9%	Reduced	Holders
Q2 2022	298,450	$45.7M	0.6%	−9,121−3.0%	Reduced	Holders
Q1 2022	307,571	$49.9M	0.5%	−11,338−3.6%	Reduced	Holders
Q4 2021	318,909	$43.2M	0.5%	−1,785−0.6%	Reduced	Holders
Q3 2021	320,694	$34.6M	0.4%	+15,357+5.0%	Added	Holders
Q2 2021	305,337	$34.4M	0.4%	+13,200+4.5%	Added	Holders
Q1 2021	292,137	$31.6M	0.4%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.